tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Geoff Meacham - 175 which are a Buy (51.02%), 136 which are a Hold (39.65%), 32 which are a Sell (9.33%)
Analyst Geoff Meacham works at BAML and is covering Healthcare, Technology sectors with 596 price targets and ratings displayed on 48 stocks. Previously, Geoff Meacham worked at BARCLAYS.
Geoff Meacham's average stock forecast success ratio is 67.7% with an average time for price targets to be met of 224.67 days.
Most recent stock forecast was given on GILD, Gilead Sciences at 08-Sep-2023.
Analyst best performing recommendations are on TYRA.
The best stock recommendation documented was for PTCT (PTC THERAPEUTICS) at 8/8/2018. The price target of $43 was fulfilled within 1 day with a profit of $2.28 (5.6%) receiving and performance score of 55.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
173
$-9.5 (-5.21%)
156
2 years 5 months ago
14/24 (58.33%)
$55.25 (44.76%)
682
Hold
166
$-16.5 (-9.04%)
175
2 years 7 months 29 days ago
26/26 (100%)
$55.25 (49.07%)
828
Buy
155
2 years 8 months 26 days ago
7/7 (100%)
$42.28 (38.07%)
395
Buy
175
$-7.5 (-4.11%)
155
2 years 9 months 17 days ago
13/17 (76.47%)
$42.47 (34.95%)
944
Hold
157
2 years 9 months 18 days ago
2/2 (100%)
$40.4 (37.02%)
256
Which stock is Geoff Meacham is most bullish on?
Which stock is Geoff Meacham is most reserved on?
What Year was the first public recommendation made by Geoff Meacham?
